toxicities

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

toxicities
Nov 14, 2024, 11:38 | Blog
Amol Akhade: Seeking insights on DYPD mutation testing in cancer treatment
Amol Akhade, Consultant Medical Oncologist at Suyog Cancer Clinics and Reliance Hospitals, shared a post…
Nov 2, 2024, 03:04 | Blog
Melvin LK Chua: Potential Increased Risks of Toxicities with Combo IO Immunotherapy and RT
Melvin LK Chua, Head of the Department of Head Neck and Thoracic Cancers, Division of…
Jun 28, 2024, 12:37 | Blog
Devika Das: A whole new Pandora’s box of toxicities with the advent of check point inhibitors
Devika Das, Medical Director at Parexel, recently shared on LinkedIn:   . “It definitely takes a…
Jun 28, 2024, 01:53 | Blog
Julia Lai-Kwon: Hope Rugo highlighting the different toxicities between different ADCs
Julia Lai-Kwon, Medical Oncologist and PhD candidate at Peter Mac Cancer Centre, recently shared a…
Jun 14, 2024, 03:24 | Blog
Guilherme Nader Marta: Our Review On the PI3K/Akt-targeted Agents
Guilherme Nader Marta, Oncology Fellow at Jules Bordet Institute, shared on X: “PI3K/Akt-targeted agents entered…
May 15, 2024, 14:18 | Blog
Talha Badar: Choice of frontline TKI for CML-CP
Talha Badar, Assistant Professor at Mayo Clinic Comprehensive Cancer Center shared a thread on Twitter/X:…
Dec 27, 2023, 13:13 | Insight
Charles Gaulin: Safety of ibrutinib in previously untreated high-risk smoldering mantle cell lymphoma
Charles Gaulin, Lymphoma/Myeloma Fellow at MD Anderson Cancer Center, shared on LinkedIn: "At ASH23, we presented…
All: 7 Posts: 1 - 100
Special Coverage